logo

For the Inventor, By the Inventor

Dreieich, Germany

Biotest Ag


USPTO Granted Patents = 45



Trademarks = 12

Forward Citations = 267

Loading Chart...
Loading Chart...

65 inventors (with patents filed for the assignee):

goldMedal Benjamin Daelken (17 out of 18 patents)

silverMedal Frank Osterroth (14 out of 14 patents)

bronzeMedal Christoph Bruecher (14 out of 14 patents)

4.  Christoph Uherek (14 out of 14 patents)

5.  Matthias Germer (11 out of 12 patents)

6.  Andrea Wartenberg-Demand (10 out of 10 patents)

7.  Gregor Schulz (8 out of 8 patents)

8.  Silke Aigner (8 out of 8 patents)

9.  Oliver Maneg (7 out of 7 patents)

10.  Dieter Rudnick (7 out of 13 patents)

11.  Chantal Zuber (7 out of 7 patents)

12.  André Engling (7 out of 7 patents)

13.  Wolfgang Moeller (6 out of 6 patents)

14.  Michael Rodemer (6 out of 6 patents)

15.  John Wijdenes (6 out of 11 patents)


Core Competencies:
Immunoglobulin Compositions
Antibody Preparations
Immunoconjugates
CD138 Targeting
Humanized Antibodies
Systemic Lupus Erythematosus
Severe Pneumonia Treatment
Viral Infections Treatment
Psoriasis Treatment
Von Willebrand Factor
Cytotoxic Side-Effects
Microorganism Detection

45 patents:

1. 12487244 - Method and kit for testing potency of immunoglobulin compositions (2025-12-02),
2. 12264191 - De-immunized factor VIII molecule and pharmaceutical compositions comprising the same (2025-04-01),
3. 12186391 - Treatment of severe community acquired pneumonia (2025-01-07),
4. 11780909 - Methods of treating viral infections by administering an antibody preparation comprising IGG, IGA and IGM (2023-10-10),
5. 11517621 - Treatment of severe community acquired pneumonia (2022-12-06),
6. 11325964 - Process for preparing immunoglobulin compositions (2022-05-10),
7. 10954290 - IgG, IgA and IgM antibody preparations, method of making and method of use in treatment (2021-03-23),
8. 10918715 - Treatment of severe community acquired pneumonia (2021-02-16),
9. 10117932 - Uses of immunoconjugates targeting CD138 (2018-11-06),
10. 10059759 - Antibody preparations (2018-08-28),
11. 9995733 - Agents for treating disease (2018-06-12),
12. 9758581 - Humanized anti-CD4 antibody with immunosuppressive properties (2017-09-12),
13. 9605066 - Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) (2017-03-28),
14. 9550831 - Method for treating psoriasis (2017-01-24),
15. 9540436 - Use of antibodies for detection of IL-10 (2017-01-10),
Biotest AG is a German biotechnology company that specializes in the development, production, and marketing of plasma proteins and biological drugs. With a focus on clinical immunology and intensive care medicine, Biotest produces a wide range of pharmaceutical products including immunoglobulins, coagulation factors, and albumin. The company's products are used in the treatment of immune deficiency disorders, bleeding disorders, and critical care conditions. Biotest operates globally and is committed to providing innovative and high-quality biopharmaceutical solutions to improve patient health.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

45 Patents

#2 in Dreieich

#1,202 in Germany

#14,979 in the World

...
Dreieich, Germany

Biotest Ag

Forward Citations = 267

65 inventors:

goldMedal Benjamin Daelken (17 out of 18 patents)

silverMedal Frank Osterroth (14 out of 14 patents)

bronzeMedal Christoph Bruecher (14 out of 14 patents)

4.  Christoph Uherek (14 out of 14 patents)

5.  Matthias Germer (11 out of 12 patents)

Please report any incorrect information to support@idiyas.com
Loading…